Back to Search Start Over

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic

Authors :
Skowronski, Danuta M.
Hottes, Travis S.
Janjua, Naveed Z.
Purych, Dale
Sabaiduc, Suzana
Chan, Tracy
De Serres, Gaston
Gardy, Jennifer
McElhaney, Janet E.
Patrick, David M.
Petric, Martin
Source :
CMAJ: Canadian Medical Association Journal. November 23, 2010, Vol. 182 Issue 17, p1851, 6 p.
Publication Year :
2010

Abstract

Background: Before pandemic (H1N1) 2009, less than 10% of serum samples collected from all age groups in the Lower Mainland of British Columbia, Canada, showed seroprotection against the pandemic (H1N1) 2009 virus, except those from very elderly people. We reassessed this profile of seroprotection by age in the same region six months after the fall 2009 pandemic and vaccination campaign. Methods: We evaluated 100 anonymized serum samples per 10-year age group based on convenience sampling. We measured levels of antibody against the pandemic virus by hemagglutination inhibition and microneutralization assays. We assessed geometric mean titres and the proportion of people with seroprotective antibody levels (hemagglutination inhibition titre [greater than or equal to] 40). We performed sensitivity analyses to evaluate titre thresholds of 80, 20 and 10. Results: Serum samples from 1127 people aged 9 months to 101 years were obtained. The overall age-standardized proportion of people with seroprotective antibody levels was 46%. A U-shaped age distribution was identified regardless of assay or titre threshold applied. Among those less than 20 years old and those 80 years and older, the prevalence of seroprotection was comparably high at about 70%. Seroprotection was 44% among those aged 20-49 and 30% among those 50-79 years. It was lowest among people aged 70-79 years (21%) and highest among those 90 years and older (88%). Interpretation: We measured much higher levels of seroprotection after the 2009 pandemic compared than before the pandemic, with a U-shaped age distribution now evident. These findings, particularly the low levels of seroprotection among people aged 50-79 years, should be confirmed in other settings and closer to the influenza season.<br />In a previous age-based survey of about 1000 anonymized serum samples collected before substantial pandemic (H1N1) 2009 activity in the Lower Mainland of the province of British Columbia, Canada, we [...]

Details

Language :
English
ISSN :
08203946
Volume :
182
Issue :
17
Database :
Gale General OneFile
Journal :
CMAJ: Canadian Medical Association Journal
Publication Type :
Periodical
Accession number :
edsgcl.243042705
Full Text :
https://doi.org/10.1503/cmaj.100910